- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Trends in biotechnology 42, 12, S. 1663-1667
- Event
-
Veröffentlichung
- (where)
-
Saarbrücken
- (who)
-
Leibniz-Institut für Neue Materialien
- (when)
-
2024
- Creator
- DOI
-
10.1016/j.tibtech.2024.06.011
- URN
-
urn:nbn:de:bsz:291:415-10772
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dey, Sourik
- Sankaran, Shrikrishnan
- Leibniz-Institut für Neue Materialien
Time of origin
- 2024
Other Objects (12)
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics